Contents x
    URSA-PHARM-003: Targeted Med Therapy Episode Plan Paid Amount
    • 27 Apr 2023
    • 1 Minute to read
    • Print
    • Dark
      Light
    Contents

    URSA-PHARM-003: Targeted Med Therapy Episode Plan Paid Amount

    • Updated on 27 Apr 2023
    • 1 Minute to read
    • Print
    • Dark
      Light
    Article summary

    Measure Description

    Among targeted medication therapy episodes, the total plan paid amount on all targeted medications. Includes URSA-PHARM episodes for any of the following targeted medication types: antidepressants, antineoplastics, beta blockers, antidiabetics, ACEI/ARBs, statins, high-risk medications (anticoagulants, oral antiplatelets, cardiac glycosides, opiate agonists, oral hypoglycemics, insulin), and any other chronic medications.

    Metadata

    • Measure Type: Rate Measure
    • Temporal Structure: Event
    • Component Class: Long-Form
    • Denominator Case Field: Episode ID
    • Target Direction: Down

    Denominator Description

    One record per medication therapy episode for any of the following targeted medication types: antidepressants, antineoplastics, beta blockers, antidiabetics, ACEI/ARBs, statins, high-risk medications (anticoagulants, oral antiplatelets, cardiac glycosides, opiate agonists, oral hypoglycemics, insulin), and any other chronic medications.

    Numerator Description

    The total plan paid amount on outpatient fills for any of the following targeted medication types.

    None.

    FAQs

    None.

    Was this article helpful?
    What's Next